Format

Send to

Choose Destination
Br J Cancer. 1988 Jan;57(1):105-8.

Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer.

Author information

1
Cancer Registry of Norway, Montebello.

Abstract

Serum samples from a biological serum bank taken several years before the diagnosis of cancer, were analysed for S-Tg and S-TSH in 43 patients with thyroid cancer and compared to 128 healthy controls matched for age, sex, geographical region and time of blood sampling. The main finding was the difference in S-Tg between cases and controls, the highest values being found in sera from cases. Relative risk of thyroid cancer increases with increasing S-Tg levels (the global test giving P less than 0.0005). Extremely high levels were found in 4 cases with follicular and 3 with anaplastic cancers. No such statistically significant difference was found in S-TSH concentration. Possible explanations for the elevated S-Tg observed several years before clinically evident malignant tumour are discussed.

PMID:
3348941
PMCID:
PMC2246681
DOI:
10.1038/bjc.1988.19
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center